Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
547.03
-0.86 (-0.16%)
At close: Nov 11, 2026, 4:00 PM EST
542.94
-4.09 (-0.75%)
After-hours: Nov 11, 2026, 7:51 PM EST
Vertex Pharmaceuticals (VRTX) Revenue by Segment
| Date | Trikafta and Kaftrio | Kalydeco | Orkambi | Symdeko and Semkevi |
|---|---|---|---|---|
| Sep 30, 2026 | 9.86B | - | - | - |
| Jun 30, 2026 | 10.08B | - | - | - |
| Mar 31, 2026 | 10.13B | - | - | - |
| Dec 31, 2025 | 10.31B | - | - | - |
| Sep 30, 2025 | 10.46B | - | - | - |
| Jun 30, 2025 | 10.39B | - | - | - |
| Mar 31, 2025 | 10.29B | - | - | - |
| Dec 31, 2024 | 10.19B | - | - | - |
| Sep 30, 2024 | 9.81B | 112.40M | 44.20M | 27.80M |
| Jun 30, 2024 | 9.50B | 225.20M | 107.20M | 61.20M |
| Mar 31, 2024 | 9.29B | 350.50M | 203.50M | 92.40M |
| Dec 31, 2023 | 8.94B | 475.50M | 326.00M | 123.00M |
| Sep 30, 2023 | 8.63B | 499.20M | 392.60M | 129.50M |
| Jun 30, 2023 | 8.37B | 525.80M | 475.80M | 134.30M |
| Mar 31, 2023 | 8.02B | 539.20M | 501.10M | 145.80M |
| Dec 31, 2022 | 7.69B | 553.20M | 510.70M | 180.00M |
| Sep 30, 2022 | 7.36B | 569.30M | 547.30M | 226.10M |
| Jun 30, 2022 | 6.90B | 592.30M | 585.60M | 269.30M |
| Mar 31, 2022 | 6.27B | 636.90M | 685.00M | 360.10M |
| Dec 31, 2021 | 5.70B | 684.20M | 771.60M | 420.40M |